<div class="content-intro"><p><span style="font-size: 14pt;"><strong>Company introduction:</strong></span></p> <p><span data-ogsc="rgb(0, 0, 0)">Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. </span></p> <p><span data-ogsc="rgb(0, 0, 0)">The Company is headquartered in London, UK, with a U.S. office in New Jersey. We believe mental health patients deserve the possibility of a better future. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). COMP360 is a potentially first-in-class treatment and has Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA), as well as Innovative Licensing and Access Pathway (ILAP) designation in the UK for TRD. </span></p> <p><span data-ogsc="rgb(0, 0, 0)">We are leading the world’s largest classic psychedelic clinical program in TRD, and building upon that robust foundation, we are executing a late-stage trial evaluating COMP360 for PTSD, another condition with high unmet need. Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability with infrequent dosing. -<span class="Apple-converted-space"> </span><a id="OWA7b9a9bdd-820c-52e3-19e0-7302f475ddce" class="x_OWAAutoLink" href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcompasspathways.com%2F&data=05%7C02%7CAlexis.Rached%40compasspathways.com%7C81c31d1d5b344b36655308deebefbd0f%7Cb94a191dccb54154868e9dcbcb3e1412%7C0%7C0%7C639207612126678649%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=gtzmMKpxYEvhVQspKpFeeyQ6S%2Fq84f%2FpCwFrBs4C4Jc%3D&reserved=0" data-auth="NotApplicable" data-outlook-id="9c215bbc-5d45-4e9b-afdf-92d15cea8a68" data-ogsc=""><u>Compass Pathways</u></a></span></p></div><p><span style="font-size: 14pt;"><strong>Job overview:</strong></span></p> <p><span style="font-size: 12pt;">The Medical Director, Medical Affairs will serve as a subject matter expert representing professional medical expertise within the Medical Affairs function, with an initial focus on treatment-resistant depression (TRD) and investigational psychedelic therapeutics. This individual will provide clinical perspective, medical judgment, and thought partnership to Medical Affairs leadership and functional teams.</span></p> <p><span style="font-size: 12pt;">The Medical Director will contribute to the execution of Medical Affairs strategy through critical evaluation of clinical evidence, development of evidence-generation initiatives, and engagement with external medical experts. Working collaboratively with Medical Affairs and cross-functional partners, the Medical Director will help ensure that scientific initiatives are clinically relevant, evidence-based, and responsive to evolving needs in psychiatric care.</span></p> <p><span style="font-size: 12pt;">The successful candidate will bring deep expertise in psychiatry, the ability to critically analyze emerging evidence, and established relationships within the medical and scientific community. This individual will be expected to proactively identify important clinical knowledge gaps, recommend approaches to addressing them, and take an active role in developing and advancing research initiatives that inform clinical practice.</span></p> <p><span style="font-size: 14pt;"><strong>Location:</strong></span> <span style="font-size: 12pt;">Remote in the United States. </span></p> <p><span style="font-size: 14pt;"><strong>Reports to:</strong></span> <span style="font-size: 12pt;">Executive Director, Medical Affairs.</span></p> <p><span style="font-size: 12pt;"><span style="font-size: 14pt;"><strong>Roles and Responsibilities<br></strong><em>(include but are not limited to)</em><strong>: </strong></span></span></p> <p><span style="font-size: 12pt;"><span style="font-size: 14pt;"><strong></strong></span></span></p> <p><strong><span style="font-size: 12pt;">Therapeutic Area Expertise and Medical Guidance</span></strong></p> <ul> <li><span style="font-size: 12pt;">Serve as a medical subject matter expert in TRD, interventional psychiatry, and emerging psychiatric treatments</span></li> <li><span style="font-size: 12pt;">Provide clinical insights and recommendations to inform Medical Affairs priorities and initiatives</span></li> <li><span style="font-size: 12pt;">Critically evaluate clinical trial results, scientific literature, and evolving treatment guidelines to inform medical strategy and decision-making</span></li> <li><span style="font-size: 12pt;">Partner with Scientific Communications, Medical Information, Medical Education, and Field Medical leadership to ensure clinical relevance and consistency across Medical Affairs activities</span></li> <li><span style="font-size: 12pt;">Identify emerging developments and clinical practice considerations that may inform future Medical Affairs priorities</span></li> <li><span style="font-size: 12pt;">Provide medical expertise to support future therapeutic indications and